Researchers at the Georgia Health Sciences University Cancer Center have identified a gene that disrupts the inflammatory process implicated in liver cancer. The study could lead to drug therapies to target TREM-1. During the 14-month study, Dr Horuzsko and his team used mouse studies to gather data on the effect of TREM-1 in the liver cells and identify potential sources for therapies. Read more here.
Study mentioned: Wu J, et al. The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma. Cancer Res. 2012 Aug 15;72(16):3977-86. PMID: 22719066
No comments:
Post a Comment